The EU’s drug regulator on Thursday backed two separate COVID-19 vaccine boosters updated to target the omicron variant and developed by rivals Moderna and Pfizer-BioNTech, as the region readies to roll out shots to ward off infections in the winter.
The new so-called bivalent shots combat the BA.1 version of omicron and the original virus first detected in China.
Read the latest updates in our dedicated coronavirus section.
The recommendations are for people aged 12 years and above who have received at least primary vaccination against COVID-19, the European Medicines Agency (EMA) said.
For the latest headlines, follow our Google News channel online or via the app.
The final go-ahead will be subject to European Commission approval, which should come in fairly quickly.
US life expectancy drops for second straight year due to COVID-19Life expectancy for Americans dropped in 2021 for the second straight year -- the biggest two-year decline in a century -- notably due to the Covid-19 ... World News
Time for COVID-19 reality check after one mln deaths this year: WHOThe World Health Organization’s COVID-19 chief said Friday it was time for a reality check on the virus after the millionth death from the disease ... Coronavirus
Moderna sues Pfizer/BioNTech for patent infringement over COVID-19 vaccineModerna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first COVID-19 vaccine approved in the ... Coronavirus
British scientists behind key COVID-19 trial launch monkeypox treatment studyThe British scientists behind one of the major therapeutic COVID-19 trials have turned their focus to treatments for monkeypox, a viral disease that ... Coronavirus
COVID-19 jab coverage in poorer countries hits 50 pct: Vaccine allianceHalf of people in poorer countries have now received two vaccine doses against COVID-19, a global vaccine alliance said Thursday, hailing progress in ... Coronavirus
Drugmakers hunt for one vaccine to target all COVID-19 variantsScientists fear the omicron shots coming this fall won’t be much better at keeping people from getting Covid-19 than what’s come before. That’s ... World News
EU regulator launches review of Pfizer-BioNTech's adapted COVID-19 vaccineThe European Medicines Agency (EMA) has started a rolling review of a variant-adapted COVID-19 vaccine from Pfizer and BioNTech, it said on ... World News